Marks I - Search Results

1

Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study.

Marks I, Lovell K, Noshirvani H, Livanou M, Thrasher S. Marks I, et al. Arch Gen Psychiatry. 1998 Apr;55(4):317-25. doi: 10.1001/archpsyc.55.4.317. Arch Gen Psychiatry. 1998. PMID: 9554427 Clinical Trial.

2

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.

Marks IM, Swinson RP, Başoğlu M, Kuch K, Noshirvani H, O'Sullivan G, Lelliott PT, Kirby M, McNamee G, Sengun S, et al. Marks IM, et al. Br J Psychiatry. 1993 Jun;162:776-87. doi: 10.1192/bjp.162.6.776. Br J Psychiatry. 1993. PMID: 8101126 Clinical Trial.

3

Beliefs, sense of control and treatment outcome in post-traumatic stress disorder.

Livanou M, Başoglu M, Marks IM, De SP, Noshirvani H, Lovell K, Thrasher S. Livanou M, et al. Among authors: marks im. Psychol Med. 2002 Jan;32(1):157-65. doi: 10.1017/s0033291701004767. Psychol Med. 2002. PMID: 11883725 Clinical Trial.

4

Social support moderates outcome in a randomized controlled trial of exposure therapy and (or) cognitive restructuring for chronic posttraumatic stress disorder.

Thrasher S, Power M, Morant N, Marks I, Dalgleish T. Thrasher S, et al. Among authors: marks i. Can J Psychiatry. 2010 Mar;55(3):187-90. doi: 10.1177/070674371005500311. Can J Psychiatry. 2010. PMID: 20370970 Clinical Trial.

5

Double-blindness procedures, rater blindness, and ratings of outcome. Observations from a controlled trial.

Başoğlu M, Marks I, Livanou M, Swinson R. Başoğlu M, et al. Among authors: marks i. Arch Gen Psychiatry. 1997 Aug;54(8):744-8. doi: 10.1001/archpsyc.1997.01830200078011. Arch Gen Psychiatry. 1997. PMID: 9283510 Clinical Trial.

6

Gender-divergent aetiological factors in obsessive-compulsive disorder.

Noshirvani HF, Kasvikis Y, Marks IM, Tsakiris F, Monteiro WO. Noshirvani HF, et al. Among authors: marks im. Br J Psychiatry. 1991 Feb;158:260-3. doi: 10.1192/bjp.158.2.260. Br J Psychiatry. 1991. PMID: 2012918

7

Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals.

Marks IM, Lelliott P, Basoglu M, Noshirvani H, Monteiro W, Cohen D, Kasvikis Y. Marks IM, et al. Br J Psychiatry. 1988 Apr;152:522-34. doi: 10.1192/bjp.152.4.522. Br J Psychiatry. 1988. PMID: 3167404 Clinical Trial.

8

Agoraphobics 5 years after imipramine and exposure. Outcome and predictors.

Lelliott PT, Marks IM, Monteiro WO, Tsakiris F, Noshirvani H. Lelliott PT, et al. Among authors: marks im. J Nerv Ment Dis. 1987 Oct;175(10):599-605. doi: 10.1097/00005053-198710000-00004. J Nerv Ment Dis. 1987. PMID: 3309186 Clinical Trial.

9

Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial.

Monteiro WO, Noshirvani HF, Marks IM, Lelliott PT. Monteiro WO, et al. Among authors: marks im. Br J Psychiatry. 1987 Jul;151:107-12. doi: 10.1192/bjp.151.1.107. Br J Psychiatry. 1987. PMID: 3315086 Clinical Trial.

10

Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder.

O'Sullivan GH, Noshirvani H, Başoğlu M, Marks IM, Swinson R, Kuch K, Kirby M. O'Sullivan GH, et al. Among authors: marks im. Br J Psychiatry. 1994 Jul;165(1):79-86. doi: 10.1192/bjp.165.1.79. Br J Psychiatry. 1994. PMID: 7802851 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

658 results

Search Page

Filters